International plasma trade
Plasma Alliance Medical Trading
A globally active pharmaceutical company participating in the specialized, highly regulated trade of human-derived blood plasma.
Company Introduction
Committed to quality, compliance, and professional integrity.
Plasma Alliance Medical Trading was founded five years ago with a clear and focused mission: to participate in international trade involving a highly specialized and strategically important human-derived raw material: blood plasma.
Blood plasma is essential for the production of life-saving plasma-derived medicinal products, including immunoglobulins, albumin, and clotting factors. As part of this highly regulated sector, our company is committed to operating with the highest standards of compliance, quality assurance, and professional integrity.
Since its establishment, Plasma Alliance Medical Trading has achieved significant growth and has become a recognized participant in the international plasma and biopharmaceutical industry. Through disciplined operational management and a strong commitment to regulatory compliance, we have built long-term partnerships with leading industry stakeholders.
These strategic collaborations enable us to contribute to a stable, reliable, and globally integrated supply chain that supports the availability of critical plasma-derived therapies.
During the COVID-19 pandemic, our company played an important role by collecting convalescent plasma suitable for direct therapeutic use. This experience further strengthened our operational capabilities and demonstrated our ability to respond effectively to urgent global healthcare needs.
As a stable, reliable, and globally active pharmaceutical company, we are committed to delivering the highest standards of product quality, compliance, and operational excellence.
Our Mission
We continuously strive to strengthen our market position while maintaining excellence across all areas of operation.
Our strategic ambition for the coming years is sustained growth, achieved through strong partnerships with leading players in the industry and responsible business practices.
Market Outlook
Positioned in a resilient and essential industry segment.
The global demand for plasma-derived medicinal products is increasing at approximately 7% annually. At present, Europe is not self-sufficient in plasma supply and produces only about 65% of the raw material required for its medicinal needs.
This structural supply gap creates a stable long-term market environment, with favorable pricing dynamics projected over the next decade.
Given the essential medical nature of plasma-derived therapies, the high regulatory barriers to entry, and sustained global demand growth, our company operates within a resilient and strategically important industry segment. These fundamentals provide a solid basis for continued expansion, predictable revenue streams, and long-term financial stability.
We believe that this strong positioning, combined with our established international partnerships and proven operational track record, makes our company a reliable and growth-oriented partner for financial institutions.
General Information
Company registration
- Trade name
- Plasma Alliance Medical Trading Ltd.
- Licence number
- ADFZ-20448
- Registration No.
- 588
- Authorizing authority
- Abu Dhabi Free Zone
- Registered seat
- Office No. EO 13, Building No.280, Taweelah, Abu Dhabi, UAE
- Date of establishment
- 18 Nov 2020
- Legal Form
- Limited Liability Company